NDC 0115-1711

aspirin and dipyridamole

Aspirin And Dipyridamole

aspirin and dipyridamole is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Impax Generics. The primary component is Aspirin; Dipyri.

Product ID0115-1711_57150d16-7ee0-470e-a96b-a4e6e92d3c8d
NDC0115-1711
Product TypeHuman Prescription Drug
Proprietary Nameaspirin and dipyridamole
Generic NameAspirin And Dipyridamole
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2016-08-29
Marketing CategoryANDA /
Application NumberANDA206964
Labeler NameImpax Generics
Substance NameASPIRIN; DIPYRI
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesCyclooxygenase
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC SPL Data Element Entries

NDC 0115-1711-13 [00115171113]

aspirin and dipyridamole CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA206964
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-01-18
Marketing End Date2017-01-18

Drug Details

NDC Crossover Matching brand name "aspirin and dipyridamole" or generic name "Aspirin And Dipyridamole"

NDCBrand NameGeneric Name
0093-3040Aspirin and DipyridamoleAspirin and Dipyridamole
0093-3064Aspirin and DipyridamoleAspirin and Dipyridamole
0115-1711aspirin and dipyridamoleaspirin and dipyridamole
0781-2141aspirin and dipyridamoleaspirin and dipyridamole
16714-964Aspirin and DipyridamoleAspirin and Dipyridamole
43598-339Aspirin and DipyridamoleAspirin and Dipyridamole
70436-092aspirin and dipyridamoleaspirin and dipyridamole
0597-0001Aggrenoxaspirin and dipyridamole
21695-656Aggrenoxaspirin and dipyridamole
68151-3971Aggrenoxaspirin and dipyridamole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.